Hospitals that participate in the 340B program offer more low-profit service lines than nonparticipants, according to research published in JAMA Internal Medicine.
“Effective January 2018, [CMS] reduced Medicare reimbursement to physicians administering discounted drugs acquired by most 340B hospital participants,” Sayeh Nikpay, PhD, MPH, from Vanderbilt University School of Medicine, and colleagues wrote. “Opponents of reform contend that 340B revenues finance safety-net services, whereas supporters contend that most participants do not direct revenue back to safety-net care.”
Uncategorized